Application of 3D Printed Insoles in Patients with Critical Limb Ischemia
Yan Fu,Yong Cheng,Hongji Pu,Deyin Zhao,Peng Qiu,Xinwu Lu
DOI: https://doi.org/10.1016/j.jvs.2024.01.111
IF: 4.86
2024-01-01
Journal of Vascular Surgery
Abstract:Critical limb ischemia (CLI) is a condition where the lower extremities lack adequate blood flow, leading to potential amputation and tissue damage. This study aims to investigate the effectiveness of an innovative intervention that customizes traditional shoe insoles to improve clinical outcomes and quality of life for CLI patients. This study examines the effects of a 3D-printed insole on foot care for patients with CLI (Fig. 1). Participants in the experimental group received customized 3D-printed insoles, while those in the control group receive traditionally manufactured insoles. The study assesses claudication distance, claudication time, pain score, SF-36 score, AOFAS score, and rehospitalization rates after surgery. Up to July 2023, 48 patients were enrolled – 24 in the experimental group, and 24 in the control group. Baseline characteristics were similar between the groups, except for smoking and myocardial infarction. During follow-up, the number of patients who suffered from foot ulcers after using the insoles did not show significant difference between the two groups (3/24 vs. 5/24; p = 0.29). After the use of insoles, the AOFAS Score, blood pressure, vitality, social functioning, mental health, and health transition of the experiment group improved significantly compared to the control group (Table 1). For patients with CLI, we can enhance traditional 3D modeling methodologies through the integration of contemporaneous computed tomography image data. By collecting foot morphologies, and formulating a composite partitioned insole, this study has the potential to reduce the incidence of foot ulcers, decrease amputation rates, improve claudication distance, claudication time and ensure a better quality of life for CLI patients.TableClinical outcomes of patients from the experimental and control groupsExperimental Group(n = 24)Control Group(n = 24)P value (Before)P value (After)Before using insolesAfter using insolesP valueBefore using insolesAfter using insolesP valueASFAS Score69.38 ± 18.5390.75 ± 8.87<0.000173.63 ± 20.9672.63 ± 17.920.85780.4605<0.0001SF-36 PF58.13 ± 31.2861.88 ± 36.210.702854.38 ± 30.4943.13 ± 29.010.05370.67600.0537 RP31.25 ± 41.8737.50 ± 44.230.617634.38 ± 45.9321.25 ± 38.370.28830.80650.1806 BP50.13 ± 21.9221.75 ± 16.36<0.000147.50 ± 26.145.76 ± 24.53>0.99990.53480.0002 GH52.00 ± 13.4952.25 ± 9.560.941352.88 ± 10.9648.63 ± 4.010.08090.80630.0935 VT70.00 ± 17.7173.75 ± 18.740.479871.88 ± 20.1147.50 ± 22.570.00040.7333<0.0001 SF51.39 ± 24.0468.06 ± 36.090.066059.72 ± 36.3138.89 ± 22.700.02130.35330.0016 RE41.67 ± 40.8337.50 ± 49.450.751737.50 ± 49.4525.00 ± 44.230.36080.75170.3608 MH56.50 ± 14.4073.50 ± 8.45<0.000155.00 ± 13.5456.00 ± 19.180.83560.71160.0002 HT34.38 ± 12.3978.13 ± 19.95<0.000131.25 ± 21.1962.50 ± 18.07<0.00010.53590.0066Table. The clinical outcomes of experimental group and control group patients.PF = physical functioning, RP = role-physical, BP = bodily pain, GH = general health, VT = vitality, SF = social functioning, RE = role-emotional, MH = mental health, HT = health transition. Open table in a new tab